is...(all about my poker chips)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hmmm 0 profit, 0 revenus, debt, negative cash flow, with a $1.52 book value.
Profitability
Profit Margin 0.00%
Operating Margin (ttm) 0.00%
Management Effectiveness
Return on Assets (ttm) -27.28%
Return on Equity (ttm) -69.81%
Income Statement
Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -34.61M
Net Income Avi to Common (ttm) -37.55M
Diluted EPS (ttm) -1.11
Quarterly Earnings Growth (yoy) N/A
Balance Sheet
Total Cash Per Share (mrq) 1.12
Total Debt (mrq) 15.33M
Total Debt/Equity (mrq) 25.76
Current Ratio (mrq) 6.69
Book Value Per Share (mrq) 1.54
Cash Flow Statement
Operating Cash Flow (ttm) -37.49M
Levered Free Cash Flow (ttm) -20.28M
Not at all man even if have 1,000% plus increases in ever aspect still doesn't look good. imho i Don't understand it other than utter manipulation by big boys to prop, trap and dump while everyone like wee lol
Said it happened in the past 2/21/12 another guy said it then too
Well above targets expecting pull back to SMA's and potential gap fill. Target was $27 now $45.
Agreed and did have a previous R/S reverse split and went down to $0.15 pretty good percentage it got the sqweeze wayyy too hard already
Some of the biggest negative returns seen and biggest negative probabilities seen..
$0.02 revenue per share, $0.06 book value
Profitability
Profit Margin 0.00%
Operating Margin (ttm) -455.18%
Management Effectiveness
Return on Assets (ttm) -53.53%
Return on Equity (ttm) -541.89%
Revenue (ttm) 3.09M
Revenue Per Share (ttm) 0.02
Quarterly Revenue Growth (yoy) -91.40%
Gross Profit (ttm) 1.69M
EBITDA -13.1M
Net Income Avi to Common (ttm) -13.63M
Diluted EPS (ttm) -0.10
Balance Sheet
Total Cash (mrq) 16.86M
Total Cash Per Share (mrq) 0.11
Total Debt (mrq) 3.11M
Total Debt/Equity (mrq) 34.49
Current Ratio (mrq) 1.75
Book Value Per Share (mrq) 0.06
Cash Flow Statement
Operating Cash Flow (ttm) -16.07M
Levered Free Cash Flow (ttm) -10.52M
I don't really think so the floats Brett big. Was in the pennies $0.00s.
Profitability
Profit Margin -3.38%
Operating Margin (ttm) -3.39%
Management Effectiveness
Return on Assets (ttm) -0.83%
Return on Equity (ttm) -2.16%
Income Statement
Revenue Per Share (ttm) 1.45
Quarterly Revenue Growth (yoy) -37.30%
Net Income Avi to Common (ttm) -9.86M
Diluted EPS (ttm) -0.05
Balance Sheet
Total Cash Per Share (mrq) 0.69
Total Debt (mrq) 115.59M
Book Value Per Share (mrq) 2.59
It's cool covered most average was $3.68
I agree $400 should be a decent mental support. Daily SMA'S are between $358 & $399
More debt than revenue, large negatives on everything (cash flow, returns and profit margins.
Profitability
Profit Margin 0.00%
Operating Margin (ttm) -300.79%
Management Effectiveness
Return on Assets (ttm) -20.00%
Return on Equity (ttm) -61.68%
Income Statement
Revenue (ttm) 6.35M
Revenue Per Share (ttm) 0.14
Quarterly Revenue Growth (yoy) -76.90%
Gross Profit (ttm) -6.66M
EBITDA -17.07M
Net Income Avi to Common (ttm) -27.36M
Diluted EPS (ttm) -0.4500
Total Debt (mrq) 9.75M
Book Value Per Share (mrq) 0.94
Cash Flow Statement
Operating Cash Flow (ttm) -14.67M
Levered Free Cash Flow (ttm) -7.67M
Book Value -$1.48, all cash flows extremely negative, Profitability all in the negative triple percentages and more.
Balance Sheet
Total Cash (mrq) 6.12M
Total Cash Per Share (mrq) 0.11
Total Debt (mrq) 915k
Total Debt/Equity (mrq) 24.12
Current Ratio (mrq) 1.13
Book Value Per Share (mrq) -1.48
Cash Flow Statement
Operating Cash Flow (ttm) -18M
Levered Free Cash Flow (ttm) -7.59M
Profitability
Profit Margin -132.51%
Operating Margin (ttm) -184.78%
Management Effectiveness
Return on Assets (ttm) -61.59%
All Simple Moving Averages SMA's well below current PPS $16.99, $20.83 & $22.93. Weekly even lower in $16's. Should have a decent pull back imo
Lots of gaps to fill for pull backs imo
Book Value Per Share $4.99
Cash Flow Statement
Operating Cash Flow (ttm) -5.49M
Levered Free Cash Flow (ttm) -9.67M
Revenue Per Share (ttm) $2.85
Agreed - Book Value Per Share $4.66
Pretty big price difference... imo
Capped
Book value $0.63 huge triple digit negative profit margins and cash flow. Only phase 1 just the beginning. Will have to hemorrhage money till completion. imho
Profitability
Profit Margin -175.03%
Operating Margin (ttm) -157.41%
Management Effectiveness
Return on Assets (ttm) -22.94%
Return on Equity (ttm) -114.04%
Income Statement
Revenue (ttm) 26.78M
Revenue Per Share (ttm) 0.34
EBITDA -41.33M
Net Income Avi to Common (ttm) -46.87M
Diluted EPS (ttm) -0.60
Balance Sheet
Total Cash Per Share (mrq) 1.31
Total Debt (mrq) 2.83M
Book Value Per Share (mrq) 0.63
Cash Flow Statement
Operating Cash Flow (ttm) -39.85M
Levered Free Cash Flow (ttm) -3.29M
Any positives in the numbers? Decent news but will need to raise money to keep anything going imho
IMMP is "ELIGIBLE" to receive development based milestones and sales based royalties. They do not have sales and drug is not out.
Profitability
Profit Margin 0.00%
Operating Margin (ttm) -300.79%
Management Effectiveness
Return on Assets (ttm) -20.00%
Return on Equity (ttm) -61.68%
Income Statement
Revenue (ttm) 4.85M
Revenue Per Share (ttm) 0.11
Quarterly Revenue Growth (yoy) -76.90%
Gross Profit (ttm) -6.66M
EBITDA -13.03M
Net Income Avi to Common (ttm) -20.89M
Diluted EPS (ttm) -0.4600
Balance Sheet
Total Cash Per Share (mrq) 0.65 will blow through it and need a serious capital raise imho
Total Debt (mrq) 7.45M
Book Value Per Share (mrq) 0.71
Cash Flow Statement
Operating Cash Flow (ttm) -11.2M
Levered Free Cash Flow (ttm) -5.86M
Had R/S a couple years ago and was $0.53 about a year ago
Profitability
Profit Margin -160.56%
Operating Margin (ttm) -168.38%
Management Effectiveness
Return on Assets (ttm) -25.20%
Return on Equity (ttm) -82.61%
Cash Flow Statement
Operating Cash Flow (ttm) -6.61M
Levered Free Cash Flow (ttm) -5.26M
Quarterly growth -76.9%, returns are negative, zero profit and cash flow is very negative.
Profitability
Profit Margin 0.00%
Operating Margin (ttm) -300.79%
Management Effectiveness
Return on Assets (ttm) -20.00%
Return on Equity (ttm) -61.68%
Income Statement
Revenue (ttm) 4.85M
Revenue Per Share (ttm) 0.11
Quarterly Revenue Growth (yoy) -76.90%
Gross Profit (ttm) -6.66M
EBITDA -13.03M
Net Income Avi to Common (ttm) -20.89M
Diluted EPS (ttm) -0.4600
Balance Sheet
Total Cash Per Share (mrq) 0.65
Total Debt (mrq) 7.45M
Book Value Per Share (mrq) 0.71
Cash Flow Statement
Operating Cash Flow (ttm) -11.2M
Levered Free Cash Flow (ttm) -5.86M
I agree it states that Novartis is in chagre and IMMP is "ELIGIBLE" to receive milestones and payments. Previous reverse split. IMHO prob going to be bled
Volume to the down side don't forget it's foreign which normally doesn't matter but have dif rules when comes to these bad larry's. Many fade to oblivion. I feel we tap the 200SMA $1.32 hot potato imho
When that happens which will imho we'll bleed pretty good then may be time to reassess
Why so salty?
Huge gap to fill in the $0.30 to $0.60 area
I bet we see huge increase and will eventually do a forward split just like GBTC. LTC has a limited supply as well unlike others. This has opportunity to blow tops off with any good volume imho
Was $0.12 & Book Value is -$0.17
Balance Sheet
Total Cash (mrq) 25.47M
Total Cash Per Share (mrq) 0.25
Total Debt (mrq) 2.8M
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.63
Book Value Per Share (mrq) -0.17
Cash Flow Statement
Operating Cash Flow (ttm) -845.12k
Levered Free Cash Flow (ttm) 27.94M
Was $0.23 & Book value per share is $0.26
Profitability
Profit Margin -27.61%
Operating Margin (ttm) -15.48%
Management Effectiveness
Return on Assets (ttm) -2.44%
Return on Equity (ttm) -52.10%
Balance Sheet
Total Cash (mrq) 1.34M
Total Cash Per Share (mrq) 0.02
Total Debt (mrq) 33.48M
Total Debt/Equity (mrq) 196.51
Current Ratio (mrq) 0.49
Book Value Per Share (mrq) 0.26
Cash Flow Statement
Operating Cash Flow (ttm) -2.42M
Levered Free Cash Flow (ttm) -11.98M
Float is increasing 33% just from second offering alone
The highs are beautiful. The industries they are in are even better. The amount of cash on hands is insane compared to market cap in a good way.
69.26M revs vs 4.57B MC
secondary public offering of 9,000,000 shares of its common stock at a public offering price of $34.00 per share dilute pps
Feel ya
With the volume yesterday I figured this would bounce a lot more. Plus cool tech
$0.37 has done over 74x or 7,400% in a year... At some point the rug pull will be ugly and prob be floating on air. Also needs to do a serious capital raise which will dilute the current structure. imho just a matter of time. How are they paying people's payroll and keeping the operations a float? Doesn't make to much sense to me...
The numbers still blow my mind and was $0.37 not long ago... Book value of -$8.35 with no cash and $0.00 total cash per share and huge DEBT...
Profit Margin -15.97%
Quarterly Revenue Growth (yoy) -28.70%
Total Cash $79k
Total Cash Per Share $0
Total Debt $264.1M
Total Debt/Equity N/A
Current Ratio 0.14
Book Value Per Share $-8.35
Huge deal Pro forma is 5x current MC and imho will be the Grainger of cannabis
Lets get high double digits def do able. Good movement.
$0.01 revenue per share.. large negative cash flow with no revenues.
Income Statement
Revenue (ttm) 3.12k
Revenue Per Share (ttm) 0.01
Gross Profit (ttm) 312k
Net Income Avi to Common (ttm) -89.53M
Diluted EPS (ttm) -2.42
Balance Sheet
Total Cash Per Share (mrq) 1.27
Book Value Per Share (mrq) 0.88
Cash Flow Statement
Operating Cash Flow (ttm) -69.85M
Levered Free Cash Flow (ttm) -41.59M
Very poor numbers negative 5 digit margin and high negative triple returns
Profitability
Profit Margin 0.00%
Operating Margin (ttm) -28,268.59%
Management Effectiveness
Return on Assets (ttm) -160.19%
Return on Equity (ttm) -573.45%